Loyin Pharmaceutical: Terminates the agreement to transfer part of the company's shares.

Roxin Pharmaceuticals announced that the "Stock Transfer Agreement" signed with stakeholders holding more than 5% of the company's shares, including Deyi Chengdu, Deyi Xinhua, Deyi Health, Desheng Health, and Kangqi Fund, has been terminated. The agreement originally planned to transfer shares accounting for 5% of the total share capital of the company, but due to triggering the relevant provisions of Article 8.3 of the "Stock Transfer Agreement," the share transfer could not be completed. The termination will not lead to changes in the controlling shareholders and actual controllers of the company, will not have a significant impact on the corporate governance structure and continuous operations, and there is no situation that harms the interests of the company and small and medium-sized investors.